All news

Radiopharm directors' listed options cancelled for nil

Alpha Vantage · Kalkine · · AI-summarised by FinFlash

Radiopharm Theranostics (ASX:RAD) reported that directors Bruce Goodwin, Ian Turner and Paul Hopper each had 1,111,111 listed options cancelled on October 16, 2026. The options, expiring July 31, 2029 with a $0.018 exercise price, were disposed of for nil consideration. Directors' shareholdings were largely unchanged and the transactions fell outside a closed period.

Read original source

RADX company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.